Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Higher Medicaid Rebates Expected To Boost Private Payer Discounts Too

Executive Summary

The recently signed health care reform law will enable private payers to seek deeper discounts on drugs than they often can now, because the law, in effect, creates a lower "best price" floor for drugs by increasing the base Medicaid drug rebate to 23.1 percent

You may also be interested in...



CMS Finally Gets An Administrator; Berwick In Until Late 2011, At Least

Before he has to face a congressional confirmation process, incoming CMS Administrator Donald Berwick will have a year and a half to demonstrate he is, as the Obama administration says, "supremely and uniquely qualified" to implement major health care reforms while overseeing the day-to-day operations of the Centers for Medicare and Medicaid Services

CMS Finally Gets An Administrator; Berwick In Until Late 2011, At Least

Before he has to face a congressional confirmation process, incoming CMS Administrator Donald Berwick will have a year and a half to demonstrate he is, as the Obama administration says, "supremely and uniquely qualified" to implement major health care reforms while overseeing the day-to-day operations of the Centers for Medicare and Medicaid Services

Strategies To Ease Short-Term Earnings Pain From Health Reform Include Cost-Cutting, Diversification

With market-based fees and increased Medicaid rebates set to start several years before drug manufacturers will see any benefit of an expanded market from health care reform, consultants are suggesting several ways to counter the short-term negative effect on earnings, including continued cost-cutting and diversification

Related Content

Topics

UsernamePublicRestriction

Register

MT101489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel